In Situ Temporospatial Characterization of the Glial Response to Prion Infection
Open Access
- 22 July 2019
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 57 (1) , 90-107
Abstract
Mammalian transmissible spongiform encephalopathies (TSEs) display marked activation of astrocytes and microglia that precedes neuronal loss. Investigation of clinical parallels between TSEs and other neurodegenerative protein misfolding diseases, such as Alzheimer’s disease, has revealed similar patterns of neuroinflammatory responses to the accumulation of self-propagating amyloids. The contribution of glial activation to the progression of protein misfolding diseases is incompletely understood, with evidence for mediation of both protective and deleterious effects. Glial populations are heterogeneously distributed throughout the brain and capable of dynamic transitions along a spectrum of functional activation states between pro- and antiinflammatory polarization extremes. Using a murine model of Rocky Mountain Laboratory scrapie, the neuroinflammatory response to prion infection was characterized by evaluating glial activation across 15 brain regions over time and correlating it to traditional markers of prion neuropathology, including vacuolation and PrPSc deposition. Quantitative immunohistochemistry was used to evaluate glial expression of iNOS and Arg1, markers of classical and alternative glial activation, respectively. The results indicate progressive upregulation of iNOS in microglia and a mixed astrocytic profile featuring iNOS expression in white matter tracts and detection of Arg1-positive populations throughout the brain. These data establish a temporospatial lesion profile for this prion infection model and demonstrate evidence of multiple glial activation states.Keywords
This publication has 83 references indexed in Scilit:
- Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitroBrain, Behavior, and Immunity, 2013
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS miceBrain, Behavior, and Immunity, 2011
- Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial NeurotoxicityJournal of Biological Chemistry, 2011
- Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulationGlia, 2010
- Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain–dependent mannerJournal of Experimental Medicine, 2010
- Analysis of Protein Levels of 24 Cytokines in Scrapie Agent-Infected Brain and Glial Cell Cultures from Mice Differing in Prion Protein Expression LevelsJournal of Virology, 2009
- Arginase: an emerging key player in the mammalian immune systemBritish Journal of Pharmacology, 2009
- Measuring prions by bioluminescence imagingProceedings of the National Academy of Sciences, 2009
- Heterogeneity of Microglial Activation in the Innate Immune Response in the BrainJournal of Neuroimmune Pharmacology, 2009
- Regulation of Inducible Nitric Oxide Synthase Gene in Glial CellsAntioxidants & Redox Signaling, 2006